• Paramita Therapeutics, Inc. Awarded Competitive Grant From the National Science Foundation

    7 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, July 21, 2021 /PRNewswire/ - Paramita Therapeutics, Inc. has been awarded a National Science Foundation Small Business Innovation Research grant for $255,990 to conduct research and development work on a novel dual-function therapeutic/vaccine product, designated as TheraVax™. TheraVax not only can block entry of SARS-CoV-2...
    Read more ...

     

  • Sorrento Announces That Its Subsidiary Levena and Its Partner Escugen Have Received Clearance to Begin Clinical Trials With Anti-TROP-2 Antibody Drug Conjugate For Multiple Solid Tumors

    7 days ago - By San Diego Biotechnology

    SAN DIEGO, July 21, 2021 - Sorrento Therapeutics, Inc. announced today its partner Escugen Biotechnology Co, Ltd. and Sorrento's subsidiary Levena Biopharma Co., Ltd. have received an approval letter from the Center for Drug Evaluation of the National Medical Products Administration...
    Read more ...

     

  • Sorrento Announces Dosing of COVID-19 Patients in Phase 2 Clinical Trial for COVIDROPS, a Highly Potent Neutralizing Antibody Against SARS-CoV-2 Including Delta and Alpha Variants of Concern, in an At-Home Outpatient Setting in United Kingdom

    7 days ago - By San Diego Biotechnology

    SAN DIEGO, July 21, 2021 - Sorrento Therapeutics, Inc. today announced that COVID-19 patients have been dosed in its Phase 2 efficacy trial. Approximately 350 outpatients with COVID-19 who are asymptomatic or have mild symptoms will be enrolled in this large double-blind, randomized clinical...
    Read more ...

     

  • Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences' CAReS Study on July 28, 2021

    7 days ago - By San Diego Biotechnology

    LA JOLLA, Calif., July 21, 2021 - Artelo Biosciences, Inc. , a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that Ladenburg Thalmann & Co...
    Read more ...

     

  • Ensysce Biosciences to Host Virtual Investor Day on July 27, 2021

    7 days ago - By San Diego Biotechnology

    SAN DIEGO, July 21, 2021 - Ensysce Biosciences, Inc. , a clinical stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today announced that it will host a virtual...
    Read more ...